Kuehne + Nagel Expands Cool Corridor Network for Pharma

Kuehne + Nagel has expanded its Cool Corridor network by adding four new dedicated temperature-controlled transport routes connecting major pharmaceutical hubs globally, including Frankfurt-Atlanta, Chicago-Narita, and additional Brussels connections. These specialized corridors are designed specifically for temperature-sensitive healthcare products and operate under Good Distribution Practice (GDP) compliance standards, enabling pharmaceutical customers to reduce Time Out of Range (TOR) exposure, a critical metric for product integrity and regulatory compliance. The structured corridors allow healthcare logistics customers to adopt lighter passive packaging solutions while maintaining temperature control, reducing both material costs and environmental impact without compromising product stability.

This expansion reflects the pharmaceutical industry's ongoing shift toward more resilient, specialized cold-chain infrastructure. As biologics, biosimilars, and personalized medicines comprise an increasingly larger share of pharmaceutical portfolios, reliable temperature-controlled networks have become competitive necessities rather than nice-to-haves. By guaranteeing minimal temperature excursions and regulatory compliance through dedicated routes, K+N is addressing a pain point that affects both logistics providers and their pharmaceutical customers, the need to balance cost efficiency with stringent product protection requirements.

For supply chain professionals managing pharmaceutical distribution, this development has meaningful implications for sourcing decisions and operational efficiency. Organizations can now negotiate lighter packaging requirements and potentially reduce overall logistics costs by leveraging these GDP-compliant corridors, while also improving supply chain visibility and reducing regulatory risk. The move also signals broader industry consolidation around specialized, technology-enabled cold-chain networks as a critical competitive differentiator in global pharmaceutical distribution.